AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemiaMarketed under AQVESME brand name…
10 December 2025 - Athletes from Beijing 2022 will be the first to have access to official Olympic Games footage as…
10 December 2025 - The first set of qualification systems for the LA28 Olympic Games has been approved by the International Olympic…
First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly…
ISLAMABAD, Pakistan, Dec. 12, 2025 /PRNewswire/ -- HTX, one of the world's leading digital asset exchanges with over 50 million…
Sri Adhikari Brothers Television Network Ltd. (SABTNL) (BSE 530943) (NSE: SABTNL) (ISIN: INE416A01044), today announced a comprehensive strategic transformation that…
Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous…
Dedicated to Nurturing a New Generation of DoctorsSupporting Hong Kong Become a Hub for Medical Innovation HONG KONG, Nov. 18,…
November 02, 2025 09:00 ET | Source: Belite Bio, Inc MHRA response is based on the Phase 3 DRAGON interim…
In Canada, lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment or…